Profile data is unavailable for this security.
About the company
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through blood purification. The Company’s blood purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its lead product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses that can lead to massive inflammation, organ failure and patient death. Its products also include ECOS-300CY, VetResQ, DrugSorb-ATR, and PuriFi. DrugSorb-ATR is an investigational device that uses equivalent polymer technology to CytoSorb to address a large unmet need for blood thinner reversal in cardiothoracic surgery. ECOS-300CY is used to reduce cytokines and other inflammatory mediators when used in an ex vivo organ perfusion system.
- Revenue in USD (TTM)34.35m
- Net income in USD-10.59m
- Incorporated2014
- Employees149.00
- LocationCytosorbents Corp305 COLLEGE ROAD EASTPRINCETON 08540United StatesUSA
- Phone+1 (973) 329-8885
- Websitehttps://cytosorbents.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baird Medical Investment Holdings Ltd | 31.86m | -3.12m | 33.37m | 143.00 | -- | 0.678 | -- | 1.05 | -0.1128 | -0.1128 | 1.22 | 1.34 | 0.4552 | 3.27 | 0.8459 | 222,797.30 | -4.48 | -- | -7.64 | -- | 86.94 | -- | -9.84 | -- | 1.67 | -0.323 | 0.3856 | -- | 17.74 | -- | 18.57 | -- | -- | -- |
| Ekso Bionics Holdings Inc | 14.75m | -10.66m | 33.38m | 61.00 | -- | 2.67 | -- | 2.26 | -5.70 | -5.70 | 7.25 | 3.69 | 0.5799 | 1.36 | 2.27 | 241,786.90 | -41.02 | -41.01 | -60.62 | -52.90 | 53.48 | 52.89 | -70.74 | -97.04 | 1.09 | -- | 0.3055 | -- | -1.94 | 5.19 | 25.45 | -- | -9.22 | -- |
| TELA Bio Inc | 77.06m | -39.00m | 36.05m | 209.00 | -- | 21.34 | -- | 0.4678 | -0.8863 | -0.8863 | 1.75 | 0.0386 | 1.34 | 2.01 | 6.85 | 368,684.20 | -68.06 | -51.29 | -96.57 | -60.70 | 67.23 | 66.26 | -50.61 | -88.02 | 2.62 | -7.25 | 0.9638 | -- | 18.56 | 35.02 | 18.91 | -- | -18.18 | -- |
| RenovoRx Inc | 928.00k | -11.11m | 36.28m | 10.00 | -- | 4.49 | -- | 39.10 | -0.4375 | -0.4375 | 0.0312 | 0.2204 | 0.0874 | -- | -- | 92,800.00 | -104.58 | -121.57 | -126.33 | -166.50 | 67.78 | -- | -1,196.66 | -90,830.23 | 5.68 | -- | 0.00 | -- | -- | -- | 13.86 | -- | -- | -- |
| Precipio Inc | 22.80m | -1.25m | 37.09m | 54.00 | -- | 2.69 | 153.26 | 1.63 | -0.835 | -0.835 | 14.63 | 7.88 | 1.20 | 18.26 | 15.31 | 422,222.20 | -6.58 | -38.01 | -8.60 | -46.98 | 44.82 | 33.80 | -5.50 | -71.34 | 1.10 | -24.19 | 0.074 | -- | 21.95 | 42.74 | 26.70 | -- | 32.31 | -- |
| Precision Optics Corporation Inc | 21.58m | -6.11m | 39.84m | 90.00 | -- | 3.64 | -- | 1.85 | -0.8505 | -0.8505 | 3.01 | 1.42 | 1.09 | 5.00 | 5.90 | 239,722.70 | -30.82 | -13.63 | -45.79 | -19.51 | 14.99 | 29.56 | -28.30 | -11.58 | 0.785 | -28.85 | 0.1375 | -- | -0.0685 | 13.98 | -95.85 | -- | 7.81 | -- |
| Neuroone Medical Technologies Corp | 12.10m | -3.61m | 40.44m | 18.00 | -- | 5.67 | -- | 3.34 | -0.0784 | -0.0784 | 0.3012 | 0.1414 | 1.50 | 1.63 | 16.79 | 672,094.40 | -44.63 | -113.64 | -61.95 | -152.08 | 67.30 | 60.94 | -29.80 | -223.44 | 3.47 | -- | 0.1519 | -- | 250.35 | 44.41 | 70.73 | -- | -7.76 | -- |
| Icecure Medical Ltd | 2.98m | -15.29m | 41.52m | 64.00 | -- | 4.46 | -- | 13.95 | -0.2586 | -0.2586 | 0.0501 | 0.1349 | 0.196 | 0.8235 | 24.39 | 46,484.38 | -100.74 | -61.14 | -155.92 | -77.11 | 35.06 | 50.17 | -513.95 | -343.95 | 1.90 | -- | 0.00 | -- | 1.92 | 15.35 | -4.55 | -- | -6.51 | -- |
| Cytosorbents Corp | 34.35m | -10.59m | 42.08m | 149.00 | -- | 4.66 | -- | 1.22 | -0.19 | -0.19 | 0.56 | 0.1436 | 0.7344 | 2.18 | 4.89 | 230,553.30 | -22.63 | -34.58 | -28.22 | -41.80 | 77.02 | 70.00 | -30.81 | -62.08 | 1.71 | -- | 0.6176 | -- | 14.51 | 7.37 | 29.16 | -- | -15.13 | -- |
| electroCore, Inc. | 29.84m | -14.16m | 42.86m | 73.00 | -- | -- | -- | 1.44 | -1.70 | -1.70 | 3.59 | -0.1405 | 1.41 | 2.63 | 29.39 | 408,698.60 | -66.70 | -65.38 | -126.40 | -87.87 | 86.04 | 80.72 | -47.46 | -159.34 | 1.33 | -- | 1.20 | -- | 57.09 | 60.15 | 36.89 | -- | -- | -- |
| Heartbeam Inc | 0.00 | -20.62m | 45.47m | 16.00 | -- | 111.65 | -- | -- | -0.6638 | -0.6638 | 0.00 | 0.0118 | 0.00 | -- | -- | 0.00 | -432.60 | -142.55 | -792.01 | -190.45 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -32.85 | -- | -- | -- |
| EUDA Health Holdings Ltd | 5.16m | -2.06m | 45.75m | 117.00 | 78.32 | -- | -- | 8.87 | 0.0155 | 0.0876 | 0.1483 | -0.0998 | 2.49 | -- | 17.10 | 44,104.96 | -100.77 | -- | -- | -- | 22.39 | -- | -40.53 | -- | 0.2084 | -46.54 | -- | -- | 8.22 | -- | -108.62 | -- | -- | -- |
| Spectral AI Inc | 23.17m | -16.37m | 47.87m | 78.00 | -- | -- | -- | 2.07 | -0.7206 | -0.7206 | 0.9706 | -0.301 | 1.72 | 28.41 | 12.12 | 297,025.70 | -121.66 | -- | -- | -- | 45.01 | -- | -70.64 | -- | 0.8252 | -11.99 | -- | -- | 63.83 | -- | 26.56 | -- | -- | -- |
| Neuraxis Inc | 3.36m | -8.37m | 49.22m | 21.00 | -- | 20.02 | -- | 14.64 | -1.02 | -1.02 | 0.4059 | 0.2311 | 0.9718 | 7.94 | 41.74 | 160,111.00 | -217.93 | -- | -1,360.57 | -- | 84.34 | -- | -224.24 | -- | 1.55 | -97.22 | 0.0789 | -- | 9.18 | -- | 42.21 | -- | -- | -- |
| Sharps Technology Inc | 2.51m | -104.37m | 49.29m | 5.00 | -- | 0.1084 | -- | 19.62 | -690.20 | -690.20 | 0.3957 | 15.68 | 0.011 | 1.81 | -- | 502,354.00 | -45.86 | -86.10 | -47.44 | -125.43 | 0.1489 | -- | -4,155.30 | -- | 3.67 | -- | 0.0173 | -- | -- | -- | 5.54 | -- | 65.50 | -- |
Data as of Feb 11 2026. Currency figures normalised to Cytosorbents Corp's reporting currency: US Dollar USD
23.04%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Avenir Corp.as of 30 Sep 2025 | 5.08m | 8.09% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.88m | 2.99% |
| Skylands Capital LLCas of 31 Dec 2025 | 1.85m | 2.95% |
| Neuberger Berman Investment Advisers LLCas of 30 Sep 2025 | 1.60m | 2.54% |
| CM Management LLCas of 31 Dec 2025 | 1.48m | 2.35% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 753.55k | 1.20% |
| Sargent Investment Group LLCas of 30 Sep 2025 | 738.70k | 1.18% |
| Geode Capital Management LLCas of 30 Sep 2025 | 601.45k | 0.96% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 313.86k | 0.50% |
| CIBC Private Wealth Advisors, Inc.as of 30 Sep 2025 | 172.65k | 0.28% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
